Three Confounded Syndromes.
Part 5 of 8 — a visual companion to Part 4: We Are Not The Same. [ ← We Are Not The Same ] [ What the Specialists Are Actually Looking At → ]
This graphic lives in the sidebar as well — particularly useful when you are preparing questions for a specialist appointment.
[ Thumbnail image of graphic — links to full graphic page ]
[ Continue: What the Specialists Are Actually Looking At → ]
Once grouped as one. Now recognized as three distinct diagnoses based on flow type and vascular architecture.
[ FULL GRAPHIC ]
How One Diagnosis Became Three
For much of the twentieth century, a patient with a port wine stain, an enlarged limb, and abnormal veins received a single label: Klippel-Trenaunay-Weber Syndrome.
The physicians behind that name — Klippel, Trenaunay, and Weber — had each described patients with overlapping features. Medicine combined their names because the conditions looked similar. Diagnosis depended on what a physician could see and feel. What the vessels were actually doing underneath was invisible.
Modern imaging changed that. Doppler ultrasound and MRI made it possible to measure blood flow through abnormal vessels — not just observe their presence, but characterize their behavior. What physicians found when they looked was that similar appearances concealed fundamentally different physiologies.
Some patients had slow-flow malformations: dilated capillaries, abnormal veins, lymphatic involvement. Blood moving through a low-pressure system. This is Klippel-Trenaunay Syndrome.
Others had something categorically different: arterial blood bypassing the normal capillary bed and entering the venous system directly, under arterial pressure. This is high-flow physiology. It is Parkes Weber Syndrome — and it comes in two anatomical forms, each with its own imaging findings and treatment requirements.
Same skin. Same enlarged limb. Same abnormal veins on the surface. Completely different biology underneath.
That single distinction — slow-flow versus high-flow — is why one historical diagnosis became three. And it is why the treatment, the risks, and the prognosis differ so dramatically between them.
The Three Syndromes
1 — Klippel-Trenaunay Syndrome (KTS) Slow-Flow Dominant
KTS is defined by a triad: capillary malformation (port wine stain), venous and lymphatic malformations, and overgrowth of affected soft tissue and bone. It predominantly affects the lower limbs — in up to 95% of patients. Blood remains within the slow-flow capillary, venous, and lymphatic systems. There is no high-flow arteriovenous shunting.
The venous and lymphatic involvement varies enormously across the KTS spectrum — from severe to subtle. This is why each patient requires individualized imaging evaluation. The port wine stain is the most consistent feature, but it tells only the surface story.
KTS is most commonly associated with somatic PIK3CA mutations — part of the PIK3CA-Related Overgrowth Spectrum (PROS). That genetic driver matters for treatment: laser therapy lightens the surface, but the genetic program building abnormal vessels continues to operate underneath. Recurrence is expected, not a failure.
Management centers on compression, sclerotherapy, physiotherapy, and monitoring. Treatment decisions should follow imaging that confirms slow-flow status and characterizes the venous and lymphatic components specifically.
Ask your specialist: Has imaging confirmed slow-flow physiology? Has the venous and lymphatic anatomy been mapped before any treatment is offered?
2 — Parkes Weber Syndrome, AVM Type High-Flow: Arteriovenous Malformation
In the AVM type of Parkes Weber Syndrome, a tangled network of abnormal vessels — called a nidus — creates direct connections between arteries and veins, bypassing the normal capillary bed entirely. Arterial blood enters the venous system under arterial pressure. Veins were never designed for this. The consequences accumulate over time.
The warmth, thrill, and bruit that characterize this condition — the heat felt over the skin, the vibration felt by hand, the sound heard through a stethoscope — are the physical signs of high-flow physiology. They are absent in slow-flow KTS. Their presence demands imaging before any other conversation about treatment takes place.
Parkes Weber Syndrome is caused by mutations in the RASA1 gene — a different genetic driver than KTS, and one that can be inherited from a parent in an autosomal dominant pattern. Genetic counseling is part of the evaluation.
Risks include bleeding, ulceration, and high-output cardiac overload as the heart compensates for blood being shunted away from normal circulation. These risks are categorically different from those of slow-flow KTS.
Management requires embolization, surgery, or combined endovascular and surgical approaches.
Laser therapy is contraindicated for high-flow AVMs. Applying PDL to a misidentified high-flow lesion can cause serious harm. Imaging to confirm flow status is not optional — it is the prerequisite for every other conversation.
Ask your specialist: Has AVM-type physiology been confirmed by imaging? Has RASA1 genetic testing been discussed? Is this center experienced in high-flow vascular anomalies?
3 — Parkes Weber Syndrome, AVF Type High-Flow: Arteriovenous Fistula
In the AVF type, arterial blood connects to veins through one or more direct fistulas — abnormal channels — without the nidus tangle of AVM-type. The distinction matters for imaging characterization and treatment planning, but both are high-flow conditions and both expose veins to arterial pressure they cannot sustain indefinitely.
The same physical signs apply: warmth, thrill, bruit. Veins distal to the fistula become arterialized — enlarged and subjected to chronic arterial pressure, which accelerates vessel damage over time. Risks include heart strain, ulceration, ischemia, and bleeding.
Management requires endovascular closure, surgical repair, or combined approaches.
Laser therapy is contraindicated here as well.
Ask your specialist: Has AVF-type physiology been distinguished from AVM-type by imaging? What is the extent of arterial involvement, and what are the cardiac monitoring requirements?
Why the History Still Matters Today
The separation of these three diagnoses is not a piece of medical history that has been fully absorbed into clinical practice everywhere. Some patients still receive a KTS diagnosis when Parkes Weber is more accurate. Some families receive laser therapy recommendations that were never validated for their actual diagnosis. Some are offered false reassurance about risks that deserve closer monitoring.
If a physician uses the older combined label — Klippel-Trenaunay-Weber Syndrome, or KTWS — the question worth asking is whether flow has been characterized. Whether imaging has been done. Whether the diagnosis is based on what the vessels look like, or on what they are actually doing.
Flow physiology is a diagnosis. What the vessels are doing — not what they look like — determines the right treatment. Imaging is not a precaution. It is the starting point.
A Note on Where This Leads
The graphic in this post shows three syndromes.
The science has named more than 100 distinct classified entities within the landscape of vascular anomalies — organized by vessel type, flow characteristics, genetic drivers, and whether the condition is isolated or syndromic.
Most readers of this post will never need all 100 of them. They need the one — or the few — that describe their child. The Vascular Anomalies Compendium exists to make that one findable within the full map, with links to dedicated pages for each entry as they are built.
If you are ready for the full map, it is there.
[ Vascular Anomalies Compendium → ]
Care4-Rare is a non-commercial patient advocacy project. Nothing here substitutes for evaluation by a qualified specialist in vascular anomalies. Bring these materials to your specialist appointment — they are designed to support that conversation, not replace it.
Sources
[VMG-001] NORD. Klippel-Trenaunay Syndrome. rarediseases.org. Updated 2024. https://rarediseases.org/rare-diseases/klippel-trenaunay-syndrome/
[VMG-002] Palermo M, et al. High-Flow and Low-Flow Vascular Malformations in KTS and Parkes Weber. Pediatr Neurol. 2025. https://www.sciencedirect.com/science/article/pii/S0887899425002668
[KTS-001] NIH MedlinePlus Genetics. Klippel-Trenaunay Syndrome. https://medlineplus.gov/genetics/condition/klippel-trenaunay-syndrome/
[KTS-002] Zannoni EM, et al. KTS in 2022: Genetic and Molecular Profile. PMC8985909. https://pmc.ncbi.nlm.nih.gov/articles/PMC8985909/
[PWS-001] NIH MedlinePlus Genetics. Parkes Weber Syndrome. https://medlineplus.gov/genetics/condition/parkes-weber-syndrome/
[CLS-001] ISSVA Classification of Vascular Anomalies (2018, updated 2025). https://www.issva.org/classification
See companion: Three Distinct Causes of PWS | Vascular Anomalies Compendium
Care 4 - Rare 